The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Uses and Use Restrictions
Funds may be used for personnel costs, consultant costs, fringe benefits, travel, equipment, supplies, contractual, data collection activities, indirect costs and other expenses.
Funds under this announcement may not be used for the following purposes:
ÃƒÂ¢Ã¢â€šÂ¬Ã‚Â¢ Student support including tuition, stipends, scholarships, bonuses, student salaries and travel;
ÃƒÂ¢Ã¢â€šÂ¬Ã‚Â¢ Subsidies or paid release time for project trainees/participants;
ÃƒÂ¢Ã¢â€šÂ¬Ã‚Â¢ Payment of temporary personnel replacement costs for the time trainees/participants are away from usual worksite during involvement in project activities; and
ÃƒÂ¢Ã¢â€šÂ¬Ã‚Â¢ Accreditation, credentialing, licensing, continuing education, and franchise fees and expenses; preadmission costs, student books and fees; promotional items and memorabilia; food and drinks; and animals laboratories.
Eligible applicants for this cooperative agreement represent a consortia or a partnership of entities such as a health professions school and a healthcare facility (e.g., between multiple health professions education programs and at least one team-based practice setting as a central partner) identified in the Public Health Service Act, Sec.
747(a) and Sec.
Federally Recognized Indian Tribal Government and Native American Organizations may apply if they are otherwise eligible.
Please refer to the funding opportunity announcement for additional information.
Please refer to the funding opportunity announcement for additional information on beneficiary eligibility.
Applicants should review the individual HRSA funding opportunity announcement issued under this CFDA program for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. OMB Circular No. A-87 applies to this program.
Aplication and Award Process
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. HRSA requires all applicants to apply electronically through Grants.gov
All qualified applications will be forwarded to an objective review committee. Based on the advice of the objective review committee, the HRSA program official with delegated authority is responsible for final selection and funding decisions.
Notification is made in writing (electronic) by a Notice of Award.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Public Health Service Act, Title VII, Section 747(a), as amended by Section 5301 of the Patient Protection and Affordable Care Act, P.L. 111-148 and Title VIII, Section 831, as amended by Section 5309 of the Patient Protection and Affordable Care Act, P.L. 111-148.
Range of Approval/Disapproval Time
From 60 to 90 days. The due date for applications under this CFDA program will be posted in the body of the funding opportunity announcement that is issued under this CFDA.
Formula and Matching Requirements
This program has no statutory formula.
Matching Requirements: Percent: 25.%.
This program has MOE requirements, see funding agency for further details.
Length and Time Phasing of Assistance
This announcement is inviting applications for project periods of five years.
Awards, made on a competitive basis, will be for a one-year budget period. See the following for information on how assistance is awarded/released: Grantee drawdown funds, as necessary, from the Payment Management System (PMS). PMS is the centralized web based payment system for HHS awards.
Post Assistance Requirements
The awardee will be required to submit annual performance and progress reports as well as status-federal financial reports (see below for details for each required report).
The awardee must submit a quarterly electronic Federal Financial Report (FFR) Cash Transaction Report via the Payment Management System within 30 days of the end of each calendar quarter.
A Federal Financial Report (SF-425) is required within 90 days of the end of each budget period.
A final report is due within 90 days after the project period ends.
If applicable, the awardee must submit a Tangible Personal Property Report (SF-428) and any related forms within 90 days after the project period ends.
New awards ("Type 1") issued under this funding opportunity announcement are subject to the reporting requirements of the Federal Funding Accountability and Transparency Act (FFATA) of 2006 (Pub.
109-282), as amended by section 6202 of Public Law 110-252, and implemented by 2 CFR Part 170.
Grant and cooperative agreement recipients must report information for each first-tier subaward of $25,000 or more in federal funds and executive total compensation for the recipient s and subrecipient s five most highly compensated executives as outlined in Appendix A to 2 CFR Part 170 (FFATA details are available online at http://www.hrsa.gov/grants/ffata.html).
Competing continuation awardees, etc.
may be subject to this requirement and will be so notified in the Notice of Award.
Expenditure reports are not applicable.
Performance monitoring is not applicable.
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133.
Awardees are required to maintain grant accounting records three years after the date they submit the FSR. If any litigation, claim, negotiation, audit or other action involving the award has been started before the expiration of the three year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular three year period, whichever is later.
(Cooperative Agreements) FY 12 $772,122; FY 13 est $771,425; and FY 14 est $788,285
Range and Average of Financial Assistance
FY 12 $772,122, FY 13 $771,425. (1 awardee).
Regulations, Guidelines, and Literature
This program is subject to the provisions of the Public Health Service Act, Title VII, Section 747, and 747(a)(b), as amended by Section 5301 of the Patient Protection and Affordable Care Act , P.L. 111-148 and Title VIII, Section 831 and 831A, as amended by Section 5309 of the Patient Protection and Affordable Care Act, P.L. 111-148.
HRSA awards are subject to the requirements of the HHS Grants Policy Statement (HHS GPS) that are applicable based on recipient type and purpose of award. The HHS GPS is available at http://www.hrsa.gov/grants.
Regional or Local Office
None. Shanita Williams, PhD, MPH, APRN 5600 Fishers Lane Room 9-61, Rockville, Maryland 20857 Email: email@example.com Phone: 301-443-1253.
Shanita Williams, PhD, MPH, APRN 5600 Fishers Lane Room 9-61, Rockville, Maryland 20857 Email: firstname.lastname@example.org Phone: 301-443-1253
Criteria for Selecting Proposals
Review criteria: Procedures for assessing the technical merit of grant applications have been instituted to provide for an objective review of applications and to assist the applicant in understanding the standards against which each application will be judged. Critical indicators have been developed for each review criterion to assist the applicant in presenting pertinent information related to that criterion and to provide the reviewer with a standard for evaluation. Review criteria are outlined in the funding opportunity announcement with specific detail and scoring points. Review Criteria are used to evaluate and rank applications.
Declara’s founder Ramona Pierson has recently raised a new $16 million for her company to further its global operations and build out a smarter team.